Unlearn.AI
Clinical Trials & Research
Unlearn.AI uses AI to generate digital twins of clinical trial patients, enabling smaller, faster, and more efficient clinical trials.
About Unlearn.AI
Unlearn.AI uses AI to create digital twins of clinical trial participants, streamlining clinical development and enabling confident decision-making.
Mission & Approach
Mission
“Driving clarity in clinical development. Powered by digital twins, data, and AI. Unlearn integrates the evidence, modeling, and reasoning behind decisions, so trial teams can commit with confidence, and so each decision builds on the last.”
AI Approach
Generative machine learning, predictive analytics, digital twin technology for patient outcome forecasting
Founding Story
Founded by Aaron Smith (Head of AI) and Jon Walsh (Chief Scientific Officer). The company emerged from research on using machine learning to model disease progression and generate digital twins of patients for clinical trials.
Product & Market
Product Stage
enterprisePrimary Market
pharmaCompany Details
- Founded
- 2017
- Headquarters
- San Francisco, CA, USA
- Employees
- 72
- Stage
- series c
- Profile last updated
- June 22, 2026
Category
Clinical Trials & ResearchOfficial Sources
Work here?
Claim this listing to update company information and connect with our audience.
Claim This Listing
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as employee counts and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.